Veru
VERU
$1.66
Share price
11.45%
Change (1 day)
23.88%
Change (1 year)
Categories
Veru (VERU) - P/B ratio
P/B ratio as of May 2024 : 4.23
According to Veru's latest financial reports the company has a price-to-book ratio of 4.23.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Veru - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.04 | -76.46% |
| 2022-12-31 | 8.67 | 172.23% |
| 2021-12-31 | 3.18 | -74.39% |
| 2020-12-31 | 12.4 | 69.17% |
| 2019-12-31 | 7.35 | 209.24% |
| 2018-12-31 | 2.38 | 74.36% |
| 2017-12-31 | 1.36 | 68.46% |
| 2016-12-31 | 0.8092 | -33.24% |
| 2015-12-31 | 1.21 | -68.61% |
| 2014-12-31 | 3.86 | -53.71% |
| 2013-12-31 | 8.34 | -0.81% |
| 2012-12-31 | 8.41 | 13.4% |
| 2011-12-31 | 7.41 | -26.92% |
| 2010-12-31 | 10.1 | -0.17% |
| 2009-12-31 | 10.2 | -8.15% |
| 2008-12-31 | 11.1 | 30.02% |
| 2007-12-31 | 8.51 | 13.62% |
| 2006-12-31 | 7.49 | -41.39% |
| 2005-12-31 | 12.8 | -19.8% |
| 2004-12-31 | 15.9 | -96.81% |
| 2003-12-31 | 499 | 1227.16% |
| 2002-12-31 | 37.6 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6372 | -84.92% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -53.66% | 🇺🇸 USA |